Attend free virtual talk on lung cancer prevention and treatment

October 20, 2023 Providence Cancer Institute of Oregon

Join us Monday, Nov. 6, as Providence Cancer Institute and Asian Health & Service Center proudly present a virtual education talk on lung cancer.

Event: What is new in screening, prevention and treatment of lung cancer
Featured Speaker: David Chen, M.D., thoracic surgeon, Providence Cancer Institute
When: Monday, Nov. 6, 10:30 a.m. – 12:00 p.m.
Where: Virtual

Register here

Guest speaker, David Chen, M.D., thoracic surgeon, Providence Cancer Institute, will discuss the US Preventative Services Task Force lung cancer screening guidelines, identify strategies for prevention of lung cancer, and explain the updated forms of treatment for lung cancer.

About Dr. David Chen

Dr. Chen completed training in general surgery at St. Luke's Roosevelt Hospital Center in New York, and Beth Israel Deaconess Medical Center in Boston, followed by cardiothoracic surgery at New York University Medical Center. His training was focused on utilizing the robotic surgery platform for a variety of thoracic health issues.

Dr. Chen completed a fellowship in surgical oncology and cancer immunotherapy at the National Cancer Institute, National Institutes of Health. During this time, he focused his efforts on applying T-cell receptor gene therapy toward solid tumors, including lung cancer.
With this experience, Dr. Chen takes a holistic approach to treating patients with cancer - using the most advanced techniques in surgery and in the laboratory to provide the best possible care for his patients.

Recognizing and preventing lung cancer for non-smokers

What is genetic and genomic medicine?

Welcome to your journey for creating a healthier you

Attend free virtual talk on lung cancer prevention and treatment

Previous Article

Next Article

Attend free virtual talk on lung cancer prevention and treatment

Previous Article

Next Article

Other content in this Stream

A study for people with GI cancers and two studies for people with advanced and early-stage lung cancer hope to develop better treatment options with the help of immunotherapy.

JACC earned re-accreditation for stem cell therapy treatment program.

Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.

SITC 2023 provides a glimpse into scientific advances and breakthroughs in cancer immunotherapy by researchers from around the world.

Genetic testing can help you learn your risk for cancer early, when you can better fight it. One mom credits genetic testing with saving her life.

Breast surgeon Lorena Gonzalez, MD, is a trusted adviser to patients, in part because she’s been in their shoes. Here she shares key information women should know.

Two new studies available at Earle A. Chiles Research Institute, at division of Providence Cancer Institute of Oregon, to evaluate new treatments for triple-negative breast cancer.

A recent study found an increased prevalence of cancer in people under 50. The study noted increases of endocrine, gastrointestinal and breast cancers in people between the ages of 30 and 39.

Radiofrequency ablation: Cancer diagnosis leads to life-improving procedure

"I found my passion early in my career. I had to educate and improve myself so I could help patients understand their diagnosis and be able to make better decisions about their care."

Providence Cancer Institute of Oregon, and research director, Earle A. Chiles Research Institute, Walter J. Urba, M.D., Ph.D., receives award for his contributions to science and community.

Learn if you may be at risk of ovarian cancer — and what you can do to reduce your risk of this disease.

Providence Cancer Institute celebrates Advanced Practice Providers Week from September 25 to 29 and recognizes their important contributions more than 25 clinics and programs.

Providence Swedish is at the forefront of new technologies that decrease pain and shorten recovery time for prostate cancer patients.

Providence Cancer Institute of Oregon announces new division director and deputy director of Hematology and Medical Oncology.

While rates of lung cancer have dropped with successful campaigns to curb smoking, lung cancer remains a problem – including for non-smokers. Learn how.

For Gynecologic Cancer Awareness Month, Providence Cancer Institute highlights a clinical trial that evaluates the safety and effectiveness of a new oral treatment for grade 1 endometrial cancer.

New trial open at Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, is enrolling patients with advanced or metastatic solid tumors or non-Hodgkin lymphoma.

What’s in your DNA matters. From your risk for developing certain diseases to what treatments might work best for you, it’s all written in your genes.

A global study co-authored by Providence researchers shows significant promise for the treatment of Chronic lymphocytic leukemia/Small Lymphocytic Lymphoma